Skip to content

Multicenter clinical trial of Trombectomy for Acute Ischemic Stroke in China (MT AISC): a retrospective study based on medical records

Multicenter clinical trial of Trombectomy for Acute Ischemic Stroke in China (MT AISC): a retrospective study based on medical records

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027457
Enrollment
Unknown
Registered
2019-11-14
Start date
2019-11-15
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

favorable prognosis group + poor prognosis group:N/A

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of acute ischemic stroke. 2. Aged >18 years. 3. Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle cerebral artery, anterior cerebral artery or basilar artery consistent with symptoms. 4. Underwent Mechanical thrombectomy (including but not limited to retrievable stents, aspiration and other vascular recanalization techniques).

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

MeasureTime frame
modified ranking scale on day (mRs) day 90;

Secondary

MeasureTime frame
NIHSS 24h post-thrombectomy;Symptomatic intracranial hemorrhage;mortality;

Countries

China

Contacts

Public ContactLi He

West China Hospital of Sichuan University

coneuro@163.com+86 028-85422114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026